30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Orthopedic Industry Revenue Reaches $51 Billion in 2018

According to our estimates to be published in THE ORTHOPAEDIC INUSTRY ANNUAL REPORT®, orthopedic industry revenue reached $51 billion worldwide in 2018 and grew 3.5% over 2017. 

Results were mixed among the largest companies as some stumbled operationally while others overperformed, due in part to early adoption of technology and entry into high-growth segments. Common strategic themes present in 2018 that will continue as part of the industry’s narrative in 2019 and beyond include connected ecosystems of products, flagship technology (e.g. robotics), portfolio-wide pull through and a growing shift to outpatient procedures.

Regulatory Report: 42 Companies that Received their First Orthopedic-Related FDA 510(k) in 2018

Small companies around the world continue to seek access to the expansive U.S. market. In 2018, 42 companies received their first ever orthopedic-related FDA 510(k) or first FDA 510(k) in a new market segment. The companies and products we mention here are excerpted from chapters of the upcoming 2019 installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®. 

4 Orthopedic Robotic and Surgical Tracking Companies to Watch

The proliferation of computer-assisted technology companies entering the joint replacement, spine and trauma markets indicates to us that industry believes there's room for product introduction and adoption in robotic- and navigation-based surgery. Here we highlight four of these companies—three new, one established but newly-restructured—and their very different intraoperative technologies.

Burst of M&A Activity at the Close of 1Q19

As was shown last week at AAOS, companies are taking strides to connect their devices with technologies that support improved patient outcomes. That connection can come in the form of M&A activity—which certainly applies to transactions announced over the month of March in joint replacement.

Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies

A summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies, including key strategies and guidance for 2019.

Page Navigation
First